Uses of polymerase chain reaction in leukemia: detection of minimal residual disease and identification of novel genetic mutations.
Lee
M S
MS
University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Stass
S A
SA
D016026:Bone Marrow Transplantation; D004250:DNA Topoisomerases, Type II / Q000235:genetics*; D006801:Humans; D007938:Leukemia / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000235:genetics / Q000628:therapy
D004250:DNA Topoisomerases, Type II